PRICE T ROWE ASSOCIATES INC /MD/
Position in TBPH — Theravance Biopharma, Inc.
CIK 80255
BALTIMORE, MD
Position in TBPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,449,471
+$229,949 QoQ
Shares Held
85,263
+13.5% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. TBPH ranks #163 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in TBPH
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,449,471 | 85,263 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,219,522 | 75,140 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,236,899 | 66,109 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $936,444 | 64,140 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $688,624 | 62,432 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $543,336 | 60,844 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $609,720 | 64,795 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $447,168 | 55,480 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $405,174 | 47,780 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $443,790 | 49,475 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $516,399 | 45,943 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $414,438 | 48,023 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $444,843 | 42,980 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $411,388 | 37,916 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $414,780 | 36,968 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $817,050 | 80,577 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $646,095 | 71,313 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $434,100 | 45,408 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $453,724 | 41,061 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $374,151 | 50,561 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $520,353 | 35,837 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $770,967 | 37,774 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,933,434 | 446,451 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,048,658 | 544,380 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $11,008,436 | 524,461 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $11,889,378 | 514,469 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||